Wells Fargo’s Marrone Bio Innovations, Inc. MBII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,558
| Closed | -$4K | – | 7925 |
|
|
2022
Q2 | $4K | Sell |
3,558
-62,852
| -95% | -$65.7K | ﹤0.01% | 6145 |
|
|
2022
Q1 | $72K | Buy |
66,410
+5,428
| +9% | +$4.1K | ﹤0.01% | 5479 |
|
|
2021
Q4 | $44K | Buy |
60,982
+53,132
| +677% | +$43K | ﹤0.01% | 6035 |
|
|
2021
Q3 | $7K | Sell |
7,850
-105,367
| -93% | -$127K | ﹤0.01% | 6317 |
|
|
2021
Q2 | $188K | Buy |
113,217
+85,320
| +306% | +$143K | ﹤0.01% | 5059 |
|
|
2021
Q1 | $58K | Sell |
27,897
-158,094
| -85% | -$328K | ﹤0.01% | 5750 |
|
|
2020
Q4 | $232K | Buy |
185,991
+97,283
| +110% | +$116K | ﹤0.01% | 5004 |
|
|
2020
Q3 | $108K | Sell |
88,708
-17,490
| -16% | -$21.3K | ﹤0.01% | 5233 |
|
|
2020
Q2 | $124K | Buy |
106,198
+33,152
| +45% | +$30.7K | ﹤0.01% | 5134 |
|
|
2020
Q1 | $59K | Sell |
73,046
-2,124
| -3% | -$2.25K | ﹤0.01% | 5284 |
|
|
2019
Q4 | $76K | Buy |
75,170
+27
| +0% | +$33 | ﹤0.01% | 5388 |
|
|
2019
Q3 | $106K | Buy |
75,143
+1,465
| +2% | +$2.07K | ﹤0.01% | 5299 |
|
|
2019
Q2 | $111K | Sell |
73,678
-5,455
| -7% | -$8.43K | ﹤0.01% | 5260 |
|
|
2019
Q1 | $121K | Buy |
79,133
+2,778
| +4% | +$4.24K | ﹤0.01% | 5068 |
|
|
2018
Q4 | $112K | Sell |
76,355
-2,551
| -3% | -$3.91K | ﹤0.01% | 5230 |
|
|
2018
Q3 | $144K | Buy |
78,906
+1,195
| +2% | +$2.32K | ﹤0.01% | 5187 |
|
|
2018
Q2 | $142K | Buy |
+77,711
| New | +$145K | ﹤0.01% | 5204 |
|
|
2017
Q2 | – | Sell |
-200
| Closed | – | – | 6534 |
|
|
2017
Q1 | $0 | Hold |
200
| – | – | ﹤0.01% | 6597 |
|
|
2016
Q4 | $0 | Hold |
200
| – | – | ﹤0.01% | 6523 |
|
|
2016
Q3 | $0 | Hold |
200
| – | – | ﹤0.01% | 6417 |
|
|
2016
Q2 | $0 | Buy |
+200
| New | +$155 | ﹤0.01% | 6425 |
|
|
2015
Q4 | – | Sell |
-285
| Closed | -$1K | – | 6494 |
|
|
2015
Q3 | $1K | Sell |
285
-2,037
| -88% | -$3.97K | ﹤0.01% | 6102 |
|
|
2015
Q2 | $5K | Buy |
2,322
+1,555
| +203% | +$4.41K | ﹤0.01% | 6032 |
|
|
2015
Q1 | $3K | Buy |
767
+122
| +19% | +$452 | ﹤0.01% | 5932 |
|
|
2014
Q4 | $2K | Buy |
645
+7
| +1% | +$19 | ﹤0.01% | 6037 |
|
|
2014
Q3 | $2K | Sell |
638
-417
| -40% | -$2.79K | ﹤0.01% | 6013 |
|
|
2014
Q2 | $12K | Buy |
1,055
+855
| +428% | +$9.69K | ﹤0.01% | 5582 |
|
|
2014
Q1 | $3K | Hold |
200
| – | – | ﹤0.01% | 5650 |
|
|
2013
Q4 | $4K | Buy |
+200
| New | +$3.25K | ﹤0.01% | 5435 |
|
Wells Fargo's MBII Position: Q3 2022 in Review
Wells Fargo sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2022, closing a stake of 3,558 shares — an estimated $4K sold.
Wells Fargo first reported a position in MBII in Q4 2013 and held it in 29 quarters. The position peaked at $232K in Q4 2020. 0 funds tracked by Wall St. Rank hold MBII as of Q3 2022.
- Wells Fargo reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2022 after selling out during the quarter.
- Wells Fargo sold 3,558 Marrone Bio Innovations, Inc. shares in Q3 2022, an estimated $4K.
- Wells Fargo first reported a position in Marrone Bio Innovations, Inc. in Q4 2013 and held it in 29 quarters.
- Wells Fargo's Marrone Bio Innovations, Inc. position peaked at $232K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2022.
Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.